Tech Company Financing Transactions
HemaQuest Pharmaceuticals Funding Round
On 11/2/2007, HemaQuest Pharmaceuticals raised $20 million in Series A financing from De Novo Ventures, Forward Ventures and Lilly Ventures.
Transaction Overview
Company Name
Announced On
11/2/2007
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series A
Investors
Proceeds Purpose
HemaQuest will use the funds primarily to support the clinical development of its lead drug candidate, an orally administered agent for treating sickle cell anemia and beta thalassemia.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
11995 El Camino Real 302
San Diego, CA 92130
USA
San Diego, CA 92130
USA
Phone
Website
Email Address
Overview
HemaQuest is a company developing proprietary small molecule therapeutics to treat serious blood disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Longenecker
Chief Financial Officer
Tamara Seymour
Chief Medical Officer
Richard Ghalie
Browse more venture capital transactions:
Prev: 11/2/2007: Corthera venture capital transaction
Next: 11/2/2007: MedAssets venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs